Annals Of Nuclear Medicine

Annals Of Nuclear Medicine

核医学年鉴

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Annals Of Nuclear Medicine》是由Springer Singapore出版社于1987年创办的英文国际期刊(ISSN: 0914-7187,E-ISSN: 1864-6433),该期刊长期致力于核医学领域的创新研究,主要研究方向为医学-核医学。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.1234...%),以发表核医学领域等方向的原创性研究为核心(研究类文章占比84.38%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在64篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Annals Of Nuclear Medicine审稿周期约为 偏慢,4-8周 。该刊近年未被列入国际预警名单,年发文量约64篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 64 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 73 / 204

64.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q2 83 / 204

59.56%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.9 SJR:0.69 SNIP:0.768
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q2 104 / 333

68%

期刊发文

  • Differentiation of lower limb vasculitis from physiological uptake on FDG PET/CT imaging

    Author: Weng, Shijia; Li, Yuan; Wang, Qian; Zhao, Yunyun; Zhou, Yunshan

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 1, pp. 26-33. DOI: 10.1007/s12149-022-01800-1

  • Outcome of patients with differentiated thyroid cancer treated with empirical radioiodine therapy on the basis of Thyroglobulin Elevation Negative Iodine Scintigraphy (TENIS) syndrome without structural disease: a retrospective cohort study

    Author: Yuan, Liyi; Wang, Jing; Pan, Liqin; Feng, Huijuan; Chen, Pan; Luo, Jiaxin; Xie, Jiahao; Xiong, Xiaoli; Wu, Juqing; Ouyang, Wei

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 1, pp. 18-25. DOI: 10.1007/s12149-022-01799-5

  • Dosimetry estimation and preliminary clinical application of [Tc-99m]Tc-HYNIC-PSMA-XL-2 in prostate cancer

    Author: Yang, Hongxing; Gao, Zhiqi; Xu, Xiaoping; Liu, Chang; Hu, Silong; Zhang, Jianping; Song, Shaoli

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 1, pp. 60-69. DOI: 10.1007/s12149-022-01804-x

  • Prognostic value of semi-quantitative parameters of F-18-FDG PET/CT in newly diagnosed multiple myeloma patients

    Author: Wan, Baoyu; Zhang, Song; Wang, Peng; Deng, Pengyi; Dai, Wenli

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 3, pp. 155-165. DOI: 10.1007/s12149-022-01812-x

  • Invasive mucinous adenocarcinoma of the lung: clinicopathological features, F-18-FDG PET/CT findings, and survival outcomes

    Author: Sun, Xiaolin; Zeng, Baozhen; Tan, Xiaoyue; Chen, Zhijian; Pan, Xiaoqiang; Jiang, Lei

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 3, pp. 198-207. DOI: 10.1007/s12149-022-01816-7

  • Tc-99m-Rituximab sentinel lymph node mapping and biopsy, the effective technique avoids axillary dissection and predicts prognosis in 533 cutaneous melanoma

    Author: Li, Nan; Zhou, Xin; Zhu, Hua; Wang, Fei; Guo, Rui; Zhang, Yan; Song, Yufei; Zhai, Shizhen; Xie, Qing; Liu, Jiayong; Li, Zhongwu; Yang, Zhi

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 3, pp. 189-197. DOI: 10.1007/s12149-022-01815-8

  • F-18-FP-CIT dopamine transporter PET findings in the striatum and retina of type 1 diabetic rats

    Author: Chen, Ping; Li, Jun; Li, Zhan; Yu, Duxia; Ma, Ning; Xia, Zian; Meng, Xianglei; Liu, Xingdang

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 4, pp. 219-226. DOI: 10.1007/s12149-022-01818-5

  • PET-guided attention for prediction of microvascular invasion in preoperative hepatocellular carcinoma on PET/CT

    Author: Ye, Zhengjie; Zhang, Jian; Wu, Nan; Chen, Song; Wang, Yutao; Yu, Zhongfei; Jin, Wei

    Journal: ANNALS OF NUCLEAR MEDICINE. 2023; Vol. 37, Issue 4, pp. 238-245. DOI: 10.1007/s12149-023-01822-3